What does CAVASTA MEDICAL do?

CAVASTA MEDICAL is a general practice in Profondeville. Private Limited, started on 16 January 2023, 2 establishments.

What is the address of CAVASTA MEDICAL?

The registered office of CAVASTA MEDICAL is located at Rue du Plateau 26, 5170 Profondeville.

Is CAVASTA MEDICAL still active?

Yes. According to the CBE (31 October 2026) CAVASTA MEDICAL is active, legal situation “Normale toestand”, started on 16 January 2023.

Is CAVASTA MEDICAL registered on Peppol?

Yes, CAVASTA MEDICAL is registered on the Peppol network with ID 0208:0797201230.

What is the enterprise number of CAVASTA MEDICAL?

The enterprise number of CAVASTA MEDICAL is BE0797201230.

When was CAVASTA MEDICAL founded?

CAVASTA MEDICAL was founded on 16 January 2023.

Who are the directors of CAVASTA MEDICAL?

According to the 2025 annual accounts, the directors of CAVASTA MEDICAL are: Caroline Vanstapel.

Is CAVASTA MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 January 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did CAVASTA MEDICAL make in 2025?

CAVASTA MEDICAL posted a profit after taxes of € 13,307 in financial year 2025.

What is the revenue of CAVASTA MEDICAL?

As a small company, CAVASTA MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 28,617.

CAVASTA MEDICAL (Private Limited) - Profondeville

Dossier CAVASTA MEDICAL, printed on 31 October 2026 from databakkes.be/en/0797201230/cavasta-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CAVASTA MEDICAL from Profondeville, company number BE0797201230, closed financial year 2025 with a result of € 13,307 after tax. For that financial year CAVASTA MEDICAL recorded a gross margin of € 28,617 and equity of € 33,289. Compared with financial year 2024, the result moved from € 5,717 to € 13,307. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Growing

€ 33,289

▲ 60% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 13,307

▲ 133% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,907

▲ 116% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 833 paid out

6 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,476

▼ 74% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 486

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 3,188

▼ 33% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 32,373 Gross margin 2023: € 32,373 First fiscal year in the series	€ 18,817 Gross margin 2024: € 18,817 ▼ 42% vs 2023 (€ 32,373) Unfavourable step	€ 28,617 Gross margin 2025: € 28,617 ▲ 52% vs 2024 (€ 18,817) Favourable step	▲ 52%
Profit after taxes	€ 13,789 Profit after taxes 2023: € 13,789 First fiscal year in the series	€ 5,717 Profit after taxes 2024: € 5,717 ▼ 59% vs 2023 (€ 13,789) Unfavourable step	€ 13,307 Profit after taxes 2025: € 13,307 ▲ 133% vs 2024 (€ 5,717) Favourable step	▲ 133%
Equity	€ 15,956 Equity 2023: € 15,956 First fiscal year in the series	€ 20,815 Equity 2024: € 20,815 ▲ 30% vs 2023 (€ 15,956) Favourable step	€ 33,289 Equity 2025: € 33,289 ▲ 60% vs 2024 (€ 20,815) Favourable step	▲ 60%
Total debts	€ 27,356 Total debts 2023: € 27,356 First fiscal year in the series	€ 9,991 Total debts 2024: € 9,991 ▼ 63% vs 2023 (€ 27,356) Favourable step	€ 6,424 Total debts 2025: € 6,424 ▼ 36% vs 2024 (€ 9,991) Favourable step	▼ 36%
Cash	€ 20,487 Cash 2023: € 20,487 First fiscal year in the series	€ 15,708 Cash 2024: € 15,708 ▼ 23% vs 2023 (€ 20,487) Unfavourable step	€ 33,907 Cash 2025: € 33,907 ▲ 116% vs 2024 (€ 15,708) Favourable step	▲ 116%
Retained profit	€ 12,956 Retained profit 2023: € 12,956 First fiscal year in the series	€ 17,815 Retained profit 2024: € 17,815 ▲ 37% vs 2023 (€ 12,956) Favourable step	€ 30,289 Retained profit 2025: € 30,289 ▲ 70% vs 2024 (€ 17,815) Favourable step	▲ 70%
Dividend	€ 833 Dividend 2023: € 833 First fiscal year in the series	€ 859 Dividend 2024: € 859 ▲ 3% vs 2023 (€ 833) Unchanged	€ 833 Dividend 2025: € 833 ▼ 3% vs 2024 (€ 859) Unchanged	▼ 3%
Bank debt	€ 3,912 Bank debt 2023: € 3,912 First fiscal year in the series	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 3,912) Favourable step	€ 486 Bank debt 2025: € 486 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 43,312 Balance sheet total 2023: € 43,312 First fiscal year in the series	€ 30,806 Balance sheet total 2024: € 30,806 ▼ 29% vs 2023 (€ 43,312) Unchanged	€ 39,713 Balance sheet total 2025: € 39,713 ▲ 29% vs 2024 (€ 30,806) Unchanged	▲ 29%

Key figures of CAVASTA MEDICAL, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CAVASTA MEDICAL?

What happened at CAVASTA MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 3, 2026 New annual accounts for financial year 2025: profit of € 13,307 (▲ 133% vs 2024). Source: NBB ↗
Jan 16, 2023 New establishment in Profondeville. KBO
Jan 16, 2023 New establishment in Profondeville. KBO
Jan 16, 2023 Start of the company according to the CBE. KBO

In short

From € 13,789 profit in 2023 to € 13,307 profit in 2025.

Paid € 13,388 in corporate taxes since 2023.

Best year ever: 2023, with € 13,789 profit.

Paid out € 2,525 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Caroline Vanstapel

CAVASTA MEDICAL

Behind CAVASTA MEDICAL is Caroline Vanstapel.

Directors

According to the 2025 annual accounts

Caroline Vanstapel

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Plateau 26

5170 Profondeville

2.340.844.481

Rue Cité du Chestia(B.V.) 1

5170 Profondeville

Active since 16 January 2023

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Poncin-Vanstapel - Oncologie et Médecine générale

€ 36,233 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0797.201.230
VAT number: BE 0797.201.230
Registered office: Rue du Plateau 26, 5170 Profondeville
Names & denominations: CAVASTA MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 January 2023
Peppol: Active · Active since 19 Dec 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗